Shepherd Center Joins Helius’ Therapeutic Experience Program Evaluating PoNS
Shepherd Center joins NYU Langone Health as the second Center of Excellence in Helius' trial evaluating evaluate PoNS therapy in MS patients.
Shepherd Center joins NYU Langone Health as the second Center of Excellence in Helius' trial evaluating evaluate PoNS therapy in MS patients.
A recent study provides Class 1 evidence supporting the efficacy of EMOPRINT for treating facial recognition deficits in people with MS.
Researchers studying twins to identify environmental and genetic influences of multiple sclerosis may have discovered precursor cells of the disease-causing T cells.
A new study led by UC San Francisco and the Australian National University, published in Neurology, suggests that in children and young adults, sun exposure may protect against multiple sclerosis.
Read MoreTreadmill walking exercise training may be an effective approach to managing the debilitating cognitive effects of multiple sclerosis, researchers suggest, in a study published in Contemporary Clinical Trials.
Read MoreHelius Medical Technologies Inc announces the launch of its Therapeutic Experience Program with NYU Langone Health as its first Center of Excellence.
Read MoreResearchers worked to determine whether vibration training — an intervention used to improve physical function for people with multiple sclerosis — could also improve patients’ cognitive function and quality of life.
Read MoreStudying mouse models of multiple sclerosis, scientists at the University of Geneva (UNIGE) have discovered exposure to cold redirects the body’s resources from the immune system to maintaining body heat, thereby decreasing the course of the disease, Genetic Engineering & Biotechnology News reports.
Read MoreInfectious mononucleosis – also known as “mono” or “the kissing disease” – in childhood or adolescence is associated with an increased risk of developing multiple sclerosis (MS) as an adult, according to a new study, Fox News reports.
Read MoreStaying active can help your multiple sclerosis, according to Self.
Read MoreThe “Legally Blonde” star shares an intimate look at her life with MS and her stem cell treatment for it in a new documentary, “Introducing, Selma Blair,” Today reports.
Read MoreThe COVID-19 pandemic appears to be stalling research into rehabilitation and quality of life (QoL) for people with multiple sclerosis (MS) in many countries worldwide, a new observational study reports, according to Multiple Sclerosis News Today.
Read MoreMultiple sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment — which depletes the B cells that contribute to the MS attacks — are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted antibody response to the vaccines, researchers suggest.
Read MorePeople with multiple sclerosis (MS) who are diagnosed with colorectal cancer may be at a higher risk of dying from cancer or other causes over the next six months to one year than people with colorectal cancer who do not have MS, according to a recent study.
Read MoreSelma Blair, one of the most high-profile celebrities open about living with multiple sclerosis, is showing support to Christina Applegate after the actress announced her own MS diagnosis, USA Today reports.
Read MoreNearly two-thirds of multiple sclerosis patients reported fatigue and half of them experienced pain in the first year after their diagnosis, Michigan Medicine researchers suggest in a recent study.
Read MoreBehavioral interventions are the best treatment options that clinicians can offer to people who experience MS-related cognitive deficits, Kessler Foundation researchers suggest.
Read MoreIt’s possible to use a synthetic thyroid hormone to regulate a gene implicated in neurodegenerative diseases like Alzheimer’s, Parkinson’s and multiple sclerosis, researchers from Oregon Health & Science University suggest.
Read More